Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Degenerative Diseases
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Stroke video
faq
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Reports
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Degenerative Diseases
Resources
Investors
Pipeline
contact us
Glycovirology Scientific Publications
featured
Galectin approach to lower covid transmission - Drug Development for clinical use
Galectin approach to lower covid transmission - Drug Development for clinical use
Gal power: the diverse roles of galectins in regulating viral infections
Gal power: the diverse roles of galectins in regulating viral infections
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Previous
load more
Molecular, Cell and Tissue Studies of Galectin-3:CD98 Interactions in IPF and COVID Pneumonitis
Molecular, Cell and Tissue Studies of Galectin-3:CD98 Interactions in IPF and COVID Pneumonitis
Assessment of Galectin-1, Galectin-3, and PGE2 Levels in Patients with COVID-19
Assessment of Galectin-1, Galectin-3, and PGE2 Levels in Patients with COVID-19
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic
Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic
Cell entry mechanisms of SARS-CoV-2
Cell entry mechanisms of SARS-CoV-2
Previous
go back